Blue Owl Capital Holdings’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Blue Owl Capital Holdings’s Portfolio FRLN Stock Details FRLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-86,654	Closed	-$552K	–	48
2023 Q4	$552K	Buy	+86,654	New	+$464K	0.13%	37

Blue Owl Capital Holdings's FRLN Position: Q1 2024 in Review

Blue Owl Capital Holdings sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q1 2024, closing a stake of 86,654 shares — an estimated $552K sold.

Blue Owl Capital Holdings first reported a position in FRLN in Q4 2023 and held it in 1 quarter. The position peaked at $552K in Q4 2023. 0 funds tracked by Wall St. Rank hold FRLN as of Q1 2024.

Blue Owl Capital Holdings reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Blue Owl Capital Holdings sold 86,654 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q1 2024, an estimated $552K.
Blue Owl Capital Holdings first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q4 2023 and held it in 1 quarter.
Blue Owl Capital Holdings's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $552K in Q4 2023.
0 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q1 2024.

Based on Blue Owl Capital Holdings's 13F filing for Q1 2024, filed 15 May 2024.